Clinical Research
VAX-D Medical Technologies has been at the forefront of research in spinal pain, since its development. So far, ten research studies have been completed on VAX-D. Seven have been published in various medical journals and an eighth will soon be added to the list. While each examines a different aspect of the VAX-D procedure, the conclusions are all in agreement: VAX-D is a valid, consistently effective safe treatment, which is a clear alternative to surgery. Below are various studies listed, to examine the different aspects of the VAX-D procedure:
Conclusion: “Prone traction delivered with VAX-D for 16 to 24 visits was associated with significant improvements in pain intensity and RMDQ scores in both short- and long-term follow-up, in patients with activity-limited LBP who had previously failed 2 non-operative interventions for their current symptoms. Causal relationships between the outcomes and the intervention cannot be made. Further study is needed using randomized comparison groups.”
Conclusion: “Following a conservative intention to treat analysis, statistically significant improvements were noted in average pain and the Roland Morris scores at short and long term follow-up, although for the Roland Morris questionnaire the minimal detectable change score was within the 95% confidence interval for mean improvement at one hundred and eighty (180) days.”
Conclusion: “VAX-D should be utilized in all patients who are poor surgical candidates and before surgery is undertaken except in the emergent conditions.”
Conclusion: “…it is possible to lower pressure in the nucleus pulposis of herniated discs below 0mm Hg when distraction tension is applied according to the protocol described for vertebral axial decompression therapy.”
Conclusion: “The results of this prospective study demonstrate that VAX-D can achieve a statistically significant improvement in pain and functional outcome for patients suffering from disc-related chronic low back pain.”
Conclusion: “VAX-D by its unique design may more precisely address the physiology of persistent low back pain than other conventional therapies. We consider it to be a front line treatment for degenerative spondylosis, facetsyndrome, disc disease, and non-surgical lumbar radiculopathy.”
Conclusion: “VAX-D therapy, however, addresses both primary and secondary causes of low back and referred pain. We thus submit that VAX-D therapy should be considered first, before the patient undergoes a surgical procedure which permanently alters the anatomy and function of the affected lumbar spine segment.”
Conclusion: “Fourteen of twenty-two peripheral nerves (64%) showing abnormal dysfunction secondary to compressive radiculopathy returned to normal function after therapeutic course of VAX-D therapy. The data from this study implies that VAX-D therapy is capable of influencing sensory nerve dysfunction associated with a compressive radiculopathy.”
Conclusion: ”Of the 23 patients who responded [to the study questionnaire], 52% had a pain level of zero, 91% were able to resume their normal daily activities, and 87% were either working or were retired without having back pain as the cause for retirement” – “and there were no complications with this treatment.”
Conclusion: “of the fifty-five (55) patients that were treated with VAX-D therapy achieved success according to the study parameters. VAX-D Therapy provides a primary treatment modality for the management of pain and disability for patients presenting in acute distress from low back pain.”
Conclusion: The average cost to industry for a patient’s VAX-D treatments alone is $3,500-4,500 as compared to an average cost of $12,000-65,000 for surgery alone (depending on surgical procedure performed).
Conclusion: “VAX-D therapy addresses the biochemical aspects of discogenic and achieves its objective through decompression. It should be utilized in patients with low back pain with or without radiculopathy who have failed conventional therapy (physiotherapy and chiropractic), and should be utilized prior to addressing surgery.”
Complete texts of all studies can be found at www.VAXD.com
News & Updates
Limited time offer!
We are offering a free consultation with the doctor this month only. Just mention that you saw this offer on the Internet.